Valeo Financial Advisors, LLC - PHIO PHARMACEUTICALS CORP ownership

PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 19 filers reported holding PHIO PHARMACEUTICALS CORP in Q2 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
Valeo Financial Advisors, LLC ownership history of PHIO PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2021$11,000
+1000.0%
4,000
+1500.0%
0.00%
Q2 2020$1,0002500.00%
Other shareholders
PHIO PHARMACEUTICALS CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Virtu Financial LLC 35,929$77,0000.01%
GSA CAPITAL PARTNERS LLP 21,278$46,0000.01%
UBS Group AG 566$1,0000.00%
BANK OF AMERICA CORP /DE/ 1$00.00%
WELLS FARGO & COMPANY/MN 33$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HSBC HOLDINGS PLC 11,337$24,0000.00%
BlackRock Inc. 19$00.00%
Citadel Advisors 12,178$26,0000.00%
Tower Research Capital LLC (TRC) 581$1,0000.00%
View complete list of PHIO PHARMACEUTICALS CORP shareholders